Here are five insights:
1. Dan Altman, MD, Nestor Tomycz, MD, and Terrence Julien, MD, implanted the patient with the Neuro-Spinal Scaffold 21 hours following spinal cord injury.
2. Dr. Julien, co-director of minimally invasive spine surgery, serves as the site’s principal investigator.
3. The INSPIRE study now has 16 patients in follow up.
4. Allegheny General Hospital is a part of the Allegheny Health Network, also in Pittsburgh.
5. The INSPIRE study tests the Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.
More articles on devices:
FDA approves ConforMIS iTotal Hip system: 5 key notes
Camber Spine Technologies appoints 2 new area sales directors: 4 things to know
Global Health Care Exchange honors Mizuho OSI as U.S. Healthcare Supplier of the Year: 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
